VANGUARD CAPITAL MANAGEMENT LLC 13D/13G Filings for Supernus Pharmaceuticals, Inc. (SUPN)

VANGUARD CAPITAL MANAGEMENT LLC 13D and 13G filings for Supernus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-04-30
2:05 pm
Purchase		2026-03-3113GSUPERNUS PHARMACEUTICALS INC C
SUPN		VANGUARD CAPITAL MANAGEMENT LLC2,900,884
5.030%		2,900,884increase
(New Position)		Filing